These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Chronic viral hepatitis B and C. Hysteria and panic are no longer appropriate]. Schwerdtfeger M; Fleig WE MMW Fortschr Med; 2000 Nov; 142(46):39-42. PubMed ID: 11132310 [No Abstract] [Full Text] [Related]
4. ABC of diseases of liver, pancreas, and biliary system: Chronic viral hepatitis. Ryder SD; Beckingham IJ BMJ; 2001 Jan; 322(7280):219-21. PubMed ID: 11159624 [No Abstract] [Full Text] [Related]
5. [Current issues in antiviral therapy of chronic hepatitis B and C]. Bakulin IG Eksp Klin Gastroenterol; 2010; (5):3-9. PubMed ID: 20731128 [TBL] [Abstract][Full Text] [Related]
6. Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review. Lieveld FI; van Vlerken LG; Siersema PD; van Erpecum KJ Ann Hepatol; 2013; 12(3):380-91. PubMed ID: 23619254 [TBL] [Abstract][Full Text] [Related]
7. [Management of hepatitis B/C in patients with HIV-infection]. Klinker H MMW Fortschr Med; 2011 May; 153(18):56-7, 59. PubMed ID: 21604601 [No Abstract] [Full Text] [Related]
8. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C]. Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255 [TBL] [Abstract][Full Text] [Related]
9. [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)]. Pár A; Tornai I; Szalay F Orv Hetil; 2007 May; 148(18):819-26. PubMed ID: 17468063 [TBL] [Abstract][Full Text] [Related]
10. [Chronic hepatitis. New therapeutic approaches on trial]. Kaiser S MMW Fortschr Med; 2000 Oct; 142(43):61. PubMed ID: 11098616 [No Abstract] [Full Text] [Related]
11. [PEG-interferons: significance for the treatment of viral hepatitis B and C]. Wedemeyer H; Cornberg M; Manns MP Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S68-75. PubMed ID: 11450618 [No Abstract] [Full Text] [Related]
12. [Antiviral therapy in children with chronic hepatitis B and children with chronic hepatitis C]. Zhang H; Zhu S Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):563-6. PubMed ID: 25224229 [No Abstract] [Full Text] [Related]
13. Disease and treatment outcome in chronic active hepatitis C with occult HBV infection. Berberova M; Mendizova A; Popchristova E; Krastev N; Genov J Hepatogastroenterology; 2003; 50(54):2009-12. PubMed ID: 14696454 [TBL] [Abstract][Full Text] [Related]
14. Renal adverse effects of interferon-alpha. Jankovic S Drug Saf; 2005; 28(7):647. PubMed ID: 15963011 [No Abstract] [Full Text] [Related]
17. HIV/viral hepatitis coinfection: the Immunology Center experience. Taylor LE Med Health R I; 2009 Jul; 92(7):234-6. PubMed ID: 19685638 [No Abstract] [Full Text] [Related]
18. [Chronic viral hepatitis: guidelines for diagnosis and therapy. When to treat--when wait?]. Füessl HS MMW Fortschr Med; 2000 Oct; 142(42):10-1. PubMed ID: 11077820 [No Abstract] [Full Text] [Related]
19. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers. Senturk H; Tahan V; Canbakan B; Uraz S; Ulger Y; Ozaras R; Tabak F; Mert A; Ozbay G Neth J Med; 2008 May; 66(5):191-5. PubMed ID: 18490796 [TBL] [Abstract][Full Text] [Related]
20. A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis. Dalekos GN; Christodoulou D; Kistis KG; Zervou EK; Hatzis J; Tsianos EV Eur J Gastroenterol Hepatol; 1998 Nov; 10(11):933-9. PubMed ID: 9872615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]